FEATURE ARTICLES
For momentum in pharmaceutical research and development, consider taking a second look at Western Pennsylvania, where capital is flowing in, innovation is picking up and growth is expected.
- March 2026 — CDMO Opportunities And Threats Report
- From Principles To Practice: Building Quality Into Generative AI-Assisted Pharma Operations
- Lilly's Toolbox For Fast Track Fill Finish Sites
- From QM To QMM For AI-Assisted Pharmaceutical Manufacturing Operations
- 4 Facility Considerations for API Manufacturing
- Ever Wonder What Running A $50B Capital Facilities Project Feels Like?
- Generative AI Can Write The Code, But Who Builds In The Quality?
PHARMA ONLINE WHITE PAPERS
-
![Medical Vials-GettyImages-547146854]( "Microbial Challenge In-Use Studies")
Microbial Challenge In-Use StudiesLearn more about how a partner with expertise can help you navigate the complex landscape of microbial challenge in-use studies and ensure the highest standards of patient care.
-
Advancing QC Efficiency With SEC-MALS System And Empower Software7/31/2025
Discover how integration transforms lab workflows to enhance molecular characterization, streamline data management, and ensure compliance for superior data integrity and operational efficiency.
-
Food Safety Digital Maturity In The Supply Chain3/17/2026
Look at how connected data and automated processes strengthen safety, improve traceability, and streamline compliance across the supply chain—offering a clear roadmap for progression.
-
Building Excellence In Pharma Manufacturing Through Rigor8/16/2025
A rigorous, proactive approach is essential for excellence in pharmaceutical manufacturing. Learn how embedding rigor in systems, workflows, and workforce capabilities improves compliance and efficiency.
-
Performance Characteristics Of The Mobius® ADC Reactor For Conjugation10/22/2024
Explore results from a series of studies evaluating the mixing performance of an innovative ADC reactor during the conjugation step utilizing a model fluid.
-
Molecular Approaches To Streamline Cell Therapy Product Analytical Testing9/26/2025
Learn how rapid molecular methods of cell therapy testing like qPCR for mycoplasma, sterility, and lentiviral quantification are key to accelerating product release and timely treatment delivery.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Product Recovery Study For Fill Finish Applications
- Enhancing Novel Developability Through Automated MS Analytics
- Quantitative Determination Of Amorphous And Crystalline Drug In Polymer Microspheres
- CDMO Uses Robotic Gloveless Isolator For Advanced Therapeutics
- Adapt Or Fail: The Urgency Of Pandemic Preparedness For Sterile Injectable Manufacturing
NEWSLETTER ARCHIVE
- 04.16.26 -- From Principles To Practice: Building Quality Into Generative AI-Assisted Pharma Operations
- 04.16.26 -- STREAM Edition: Batch Vs. Continuous Process Evolution
- 04.15.26 -- Innovation That's Redefining Aseptic Filling
- 04.15.26 -- Beyond Capacity: Fill/Finish Capabilities That Matter
- 04.14.26 -- From QM To QMM For AI-Assisted Pharmaceutical Manufacturing Operations
INDUSTRY NEWS
-
![FDA Logo on phone screen-GettyImages-2208861549]( "Høeg In, Pazdur Out At The FDA")
Høeg In, Pazdur Out At The FDAWhat an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
-
![business peope negotiating-GettyImages-637902194]( "9 Drugs Granted Fast Track By FDA's Voucher Program")
9 Drugs Granted Fast Track By FDA's Voucher ProgramWith targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
![Pharmaceutical sorting machine, pills-GettyImages-1499814881]( "Leaders In The Excipient Market: Region And Type")
Leaders In The Excipient Market: Region And TypeThough North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
-
![GettyImages-2189405678-GLP-1-obesity]( "Pfizer Strengthens Obesity Foothold With Metsera Acquisition")
Pfizer Strengthens Obesity Foothold With Metsera AcquisitionAfter discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
![weight loss, diabetes, insulin pen-GettyImages-2196049931]( "FDA Cracks Down On GLP-1 Imports")
FDA Cracks Down On GLP-1 ImportsGLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Flow Sciences Appoints Kent Lupino As Chief Marketing Officer4/14/2026
Flow Sciences, Inc., a global leader in advanced containment solutions for laboratory and pharmaceutical environments, today announced the appointment of Kent Lupino as chief marketing officer. Lupino will be based at the company's new office in North Carolina's Research Triangle Park (RTP) and will report directly to Chief Executive Officer Jonathan Mann.
-
Groninger To Debut "Lifecycle Solutions" At INTERPHEX 20264/14/2026
At the show, groninger USA will debut its newly launched service concept, “Lifecycle Solutions.” The program consolidates all services across the entire lifecycle of the company’s machines – from commissioning and continuous optimization to modernization and retrofit. In doing so, it reflects the company’s ongoing commitment to service, quality, and providing long-term solutions availability.
-
Symbiosis Expands Commercial Capabilities With Addition Of New Stability Chamber4/1/2026
Symbiosis Pharmaceutical Services (Symbiosis), a Contract Development and Manufacturing Organisation (CDMO) specialising in the sterile GMP manufacturer of injectable drug products, has expanded its Quality Control (QC) laboratory with the installation of a new 30°C stability chamber.
